A maltose phosphorylase mutant, its immobilized enzyme, preparation method and application

By performing site-directed mutagenesis and immobilization on maltose phosphorylase, the TbMP_V1 mutant was obtained, which solved the problems of insufficient thermal stability and catalytic performance of the enzyme, achieving efficient and stable maltose synthesis and reducing production costs.

CN123107955APending Publication Date: 2026-11-17HANGZHOU FAZHELO BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611535580.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-30
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

The industrial application of maltose phosphorylase suffers from insufficient thermal stability and limited catalytic performance, which restricts the increase in reaction temperature and immobilization efficiency, thereby increasing production costs.

Method used

By performing site-directed mutagenesis on maltose phosphorylase, a mutant TbMP_V1 was obtained and prepared as an immobilized enzyme. Maltose was synthesized using enzyme catalysis under specific conditions.

Benefits of technology

It significantly improves the catalytic activity and thermal stability of maltose phosphorylase, enhances enzyme reusability, reduces production costs, and is suitable for both free and immobilized enzyme systems.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123107955A_ABST
    Figure CN123107955A_ABST
Patent Text Reader

Abstract

This invention discloses a maltose phosphorylase mutant, its encoding gene, a recombinant vector constructed from the encoding gene, recombinant microorganisms obtained by transforming the recombinant vector, and the immobilized enzyme prepared from them, and its application in catalyzing the synthesis of maltose from D-glucose and β-D-glucose-1-phosphate. This invention also discloses a method for preparing the immobilized enzyme and its application in catalyzing the synthesis of maltose from D-glucose and β-D-glucose-1-phosphate. Compared to wild-type maltose phosphorylase TbMP, the maltose phosphorylase mutant TbMP_V1 of this invention exhibits significantly improved catalytic activity and thermostability, making it suitable for both free enzyme catalytic systems and continuous operation systems using immobilized enzymes. The maltose phosphorylase mutant TbMP_V1 and its immobilized enzyme provided by this invention have significant advantages such as high activity, good thermostability, and good reusability, which can effectively reduce production costs and have broad industrial application prospects.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of enzyme engineering technology, specifically to a maltose phosphorylase mutant, its immobilized enzyme, preparation method, and application. Background Technology

[0002] Maltose phosphorylase (MP) belongs to the 65th family of glycoside hydrolases (GH65). It catalyzes the reaction of D-glucose and β-D-glucose-1-phosphate (β-G1P) to produce maltose and inorganic phosphate, and has dual catalytic functions of reversible phosphorylation and glycosyl transfer.

[0003] The forward phosphorylation reaction of maltose phosphorylase can be used for the detection of maltose and phosphate and the production of β-G1P; the reverse synthesis reaction uses β-G1P as a glycosyl donor to synthesize disaccharides and glycosides, which has important application value in the enzymatic synthesis of high-value-added products such as trehalose-6-phosphate and the preparation of high-purity maltose.

[0004] However, the industrial application of maltose phosphorylase still faces two major challenges: first, the enzyme's insufficient thermal stability limits the increase in reaction temperature, reduces immobilization efficiency and the number of times the enzyme can be reused, and significantly increases production costs; second, the catalytic performance of natural enzymes is limited, making it difficult to meet the demands of efficient industrial conversion. Therefore, discovering novel maltose phosphorylases with excellent stability, and then using protein engineering techniques such as site-directed mutagenesis to modify them molecularly to obtain mutants with higher thermal stability and better catalytic efficiency, is of great significance for promoting the large-scale application of this enzyme in the field of industrial biomanufacturing. Summary of the Invention

[0005] To address the problems existing in the prior art, this invention provides a maltose phosphorylase mutant, its immobilized enzyme, its preparation method, and its application.

[0006] The present invention adopts the following technical solution:

[0007] The first aspect of this invention provides a maltose phosphorylase mutant, wherein the maltose phosphorylase mutant is maltose phosphorylase mutant TbMP_V1;

[0008] The maltose phosphorylase mutant TbMP_V1 is obtained by mutating serine at position 368 to leucine, valine at position 551 to aspartic acid, and asparagine at position 698 to histidine in wild-type maltose phosphorylase TbMP; the amino acid sequence of wild-type maltose phosphorylase TbMP is shown in SEQ ID NO:5.

[0009] A second aspect of the present invention provides the gene for the above-mentioned maltose phosphorylase mutant.

[0010] A third aspect of the present invention provides a recombinant vector constructed from the encoding gene of the above-mentioned maltose phosphorylase mutant.

[0011] The fourth aspect of the present invention provides recombinant microorganisms obtained by transformation of the above-described recombinant vector.

[0012] The fifth aspect of the present invention provides the application of the above-mentioned maltose phosphorylase mutant in the catalytic synthesis of maltose from D-glucose and β-D-glucose-1-phosphate. In application, the maltose phosphorylase mutant is used as a catalyst, and D-glucose and β-D-glucose-1-phosphate are used as substrates. Under controlled temperature and stirring speed conditions, the enzyme-catalyzed synthesis of maltose is carried out in a reaction medium.

[0013] Furthermore, the reaction medium is a 10-100 mM Tris-HCl buffer solution with a pH of 7.0-8.0, the final concentration of maltose phosphorylase mutant is 0.025-1.5 mg / mL, the final concentration of D-glucose is 100-400 mg / mL, the final concentration of β-D-glucose-1-phosphate is 100-300 mg / mL, the temperature is controlled at 40-50°C, the stirring speed is 100-300 rpm, and the reaction time is 1-5 h.

[0014] The sixth aspect of the present invention provides an immobilized enzyme prepared from the above-mentioned maltose phosphorylase mutant.

[0015] Further, the immobilized enzyme is prepared by the following steps: using 10-100 mM Tris-HCl buffer (pH 7.0-8.0) as a solvent, the maltose phosphorylase mutant and amino resin are added, wherein the mass ratio of the maltose phosphorylase mutant to the amino resin is 10-100 mg: 1 g, the amino resin includes LX-1000NH amino resin, and 1% (v / v)-5% (v / v) glutaraldehyde and 1% (v / v)-5% (v / v) polyethyleneimine are added, wherein the glutaraldehyde is calculated as 50% (wt) glutaraldehyde, the polyethyleneimine is a liquid with a purity ≥99% (wt), the immobilization temperature is 4-10℃, the stirring speed is 20-100 rpm, the immobilization time is 0.5-6 h, and the enzyme is obtained by filtration and washing.

[0016] The seventh aspect of the present invention provides the application of the above-mentioned immobilized enzyme in the catalytic synthesis of maltose from D-glucose and β-D-glucose-1-phosphate. In application, the immobilized enzyme is used as a catalyst, D-glucose and β-D-glucose-1-phosphate are used as substrates, and the enzyme-catalyzed synthesis of maltose is carried out in a reaction medium under controlled temperature and stirring speed conditions.

[0017] Further, the reaction medium is a 10-100 mM Tris-HCl buffer solution with a pH of 7.0-8.0, the final concentration of the immobilized enzyme is 50-200 mg / mL, the final concentration of D-glucose is 100-400 mg / mL, the final concentration of β-D-glucose-1-phosphate is 100-300 mg / mL, the temperature is controlled at 40-50°C, the stirring speed is 100-300 rpm, and the reaction time is 1-5 h.

[0018] The beneficial effects of this invention are:

[0019] This invention utilizes site-directed mutagenesis of maltose phosphorylase to obtain a maltose phosphorylase mutant, TbMP_V1, with significantly enhanced catalytic activity and thermostability, achieving an enzyme activity of 48.1 U / mg (compared to 30.2 U / mg for wild-type maltose phosphorylase TbMP). Regarding thermostability, the maltose phosphorylase mutant TbMP_V1 retains 51.1% of its relative enzyme activity after treatment at 60 °C for 50 h, significantly superior to the wild-type maltose phosphorylase TbMP (30.5%). The maltose phosphorylase mutant TbMP_V1 is suitable for both free enzyme catalytic systems and immobilized enzyme continuous operation systems.

[0020] The free maltose phosphorylase mutant TbMP_V1 was used to catalyze the synthesis of maltose from D-glucose and β-D-glucose-1-phosphate (β-G1P), achieving a yield of 92.1%, while the wild-type maltose phosphorylase TbMP yielded only 64.5%.

[0021] Further, after the maltose phosphorylase mutant TbMP_V1 was prepared as an immobilized enzyme, its yield of maltose synthesis from D-glucose and β-D-glucose-1-phosphate (β-G1P) was 92.5%, and it still retained 85.8% of the relative enzyme activity after 30 uses (the immobilized enzyme prepared from wild-type maltose phosphorylase TbMP had a yield of only 66.5% and retained only 22.3% of the relative enzyme activity after 30 uses), demonstrating good catalytic performance, operational stability and reusability.

[0022] In summary, the maltose phosphorylase mutant TbMP_V1 and its immobilized enzyme provided by this invention have significant advantages such as high activity, good thermal stability, and good reusability, which can effectively reduce production costs and have broad prospects for industrial application. Attached Figure Description

[0023] Figure 1 The results of SDS-PAGE analysis of maltose phosphorylase TsMP and its mutants in Example 3 are shown.

[0024] Figure 2The results of SDS-PAGE analysis of maltose phosphorylase TcMP and its mutants in Example 3 are shown.

[0025] Figure 3 The results of SDS-PAGE analysis of maltose phosphorylase TbMP and its mutants in Example 3 are shown.

[0026] Figure 4 The results show the thermostability of different maltose phosphorylases and mutants.

[0027] Figure 5 The results show the yield comparison of maltose synthesis from D-glucose and β-D-glucose-1-phosphate catalyzed by free maltose phosphorylase and its mutant.

[0028] Figure 6 The results show the yield of maltose synthesized from D-glucose and β-D-glucose-1-phosphate catalyzed by immobilized enzymes.

[0029] Figure 7 The results show the relative enzyme activity measured after 30 cycles of immobilized enzyme application. Detailed Implementation

[0030] The present invention will be further explained below with reference to the embodiments and accompanying drawings. The following embodiments are for illustrative purposes only and are not intended to limit the scope of the invention.

[0031] Unless otherwise specified in the following implementation plan, the test conditions are generally as per standard test conditions or the test conditions recommended by the reagent company. Unless otherwise specified, all materials and reagents used are commercially available.

[0032] The culture medium formulations involved in the following examples are as follows:

[0033] SOC liquid medium (1 L): 20 g tryptone, 5 g yeast extract, 0.5 g sodium chloride, 10 mL 250 mM potassium chloride, 10 mL 1 M magnesium chloride, 10 mL 1 M magnesium sulfate, 5 mL 1 M D-glucose (added separately before use after sterilization by filtration through a 0.22 μm filter membrane); pH 7.2.

[0034] LB liquid medium (1 L): 10 g tryptone, 5 g yeast extract, 10 g sodium chloride; pH 7.0.

[0035] LB solid medium is made by adding 20 g of agar powder to 1 L of LB liquid medium.

[0036] All of the above culture media need to be autoclaved at 121°C for 20 min.

[0037] Example 1: Construction of recombinant Escherichia coli with maltose phosphorylation enzyme

[0038] I. Construction of Recombinant Plasmids

[0039] Iron-loving thermophilic bacteria ( Thermoanaerobacter siderophilus The gene fragment encoding wild-type maltose phosphorylase TsMP in the genome (gene sequence as shown in SEQ ID NO: 2, amino acid sequence as shown in SEQ ID NO: 1), *Clostridium thermophilum* ( Thermoclostridium caenicola The gene fragment encoding wild-type maltose phosphorylase TcMP in the genome (gene sequence as shown in SEQ ID NO: 4, amino acid sequence as shown in SEQ ID NO: 3), *Hydroxobacterium thermophilum* ( Thermohalobacter berrensis The gene fragment encoding wild-type maltose phosphorylase TbMP in the genome (gene sequence as shown in SEQ ID NO: 6, amino acid sequence as shown in SEQ ID NO: 5) was synthesized by Sangon Biotech (Shanghai) Co., Ltd. after codon optimization of E. coli. The optimized gene fragment was then constructed into the vector pET-28a(+) to obtain recombinant plasmids.

[0040] II. Transformation of Escherichia coli with recombinant plasmids E. coli BL21(DE3)

[0041] The recombinant plasmid obtained in step one of Example 1 was transformed into the strain using a heat shock method. E. coli In BL21(DE3), the specific steps are as follows: Add 10 μL of 1 ng / μL recombinant plasmid to each tube of 100 μL of E. coli BL21(DE3) competent cell suspension (OD approximately 0.4-0.6), mix gently, and incubate on ice for 30 min. Transfer to a 42℃ water bath and heat shock for 90 s. Quickly transfer to an ice bath and cool for 3 min. Add 700 μL of antibiotic-free SOC liquid medium to each tube and incubate at 37℃ and 100 rpm on a shaker for 40 min. After incubation, centrifuge the bacterial culture at 4℃ and 12000 rpm for 10 min, discard 600 μL of supernatant, mix the remaining bacterial culture, and spread it onto LB solid medium plates containing 50 μg / mL kanamycin sulfate. Incubate at 37℃ inverted overnight.

[0042] Selection of positive clones: Four clones were selected and transferred to 5 mL of LB liquid medium containing 50 μg / mL kanamycin sulfate. The cultures were incubated at 37°C and 200 rpm for 8 h. Plasmids were extracted using the Mini-Plasmid Rapid Isolation Kit (Beijing Bodatech Biotechnology Co., Ltd.). 20 μL of plasmid was taken and sent to Sangon Biotech (Shanghai) Co., Ltd., where DNA sequencing confirmed successful construction.

[0043] Example 2 Construction of recombinant Escherichia coli with maltose phosphorylase mutant

[0044] I. Construction of Recombinant Plasmids

[0045] The sequence of wild-type maltose phosphorylase in step one of Example 1 was analyzed, and multiple mutants were designed using bioinformatics methods, as shown in Table 1.

[0046] Table 1

[0047]

[0048] TsMP_V1 is a wild-type maltose phosphorylase TsMP with the following mutations: glutamine at position 82 is mutated to proline, histidine at position 351 is mutated to threonine, threonine at position 419 is mutated to histidine, proline at position 420 is mutated to asparagine, and lysine at position 421 is mutated to glutamate.

[0049] TsMP_V2 is a wild-type maltose phosphorylase TsMP with histidine at position 351 mutated to threonine, proline at position 420 mutated to asparagine, and lysine at position 421 mutated to glutamic acid.

[0050] TcMP_V1 is a wild-type maltose phosphorylase TcMP with a mutation at position 136 (asparagine) to glutamic acid, position 202 (serine) to valine, and position 397 (threonine) to arginine.

[0051] TcMP_V2 is a wild-type maltose phosphorylase TcMP with an asparagine mutation at position 136 replaced by glutamate and a serine mutation at position 202 replaced by valine.

[0052] TbMP_V1 is a wild-type maltose phosphorylase TbMP with serine at position 368 mutated to leucine, valine at position 551 mutated to aspartic acid, and asparagine at position 698 mutated to histidine.

[0053] TbMP_V2 is a wild-type maltose phosphorylase TbMP with a serine mutation at position 368 replaced by leucine and an asparagine mutation at position 698 replaced by histidine.

[0054] All the mutants were codon optimized by Sangon Biotech (Shanghai) Co., Ltd., and the optimized gene fragments were synthesized and constructed into the vector pET-28a(+) to obtain recombinant plasmids.

[0055] II. Transformation of Escherichia coli with recombinant plasmids E. coli BL21(DE3)

[0056] The recombinant plasmid obtained in step one of Example 2 was transformed into the strain using a heat shock method. E. coli In BL21(DE3), the specific steps are as follows: Add 10 μL of 1 ng / μL recombinant plasmid to each tube of 100 μL of E. coli BL21(DE3) competent cell suspension (OD approximately 0.4-0.6), mix gently, and incubate on ice for 30 min. Transfer to a 42℃ water bath and heat shock for 90 s. Quickly transfer to an ice bath and cool for 3 min. Add 700 μL of antibiotic-free SOC liquid medium to each tube and incubate at 37℃ and 100 rpm on a shaker for 40 min. After incubation, centrifuge the bacterial culture at 4℃ and 12000 rpm for 10 min, discard 600 μL of supernatant, mix the remaining bacterial culture, and spread it onto LB solid medium plates containing 50 μg / mL kanamycin sulfate. Incubate overnight at 37℃ inverted.

[0057] Selection of positive clones: Four clones were selected and transferred to 5 mL of LB liquid medium containing 50 μg / mL kanamycin sulfate. The cultures were incubated at 37°C and 200 rpm for 8 h. Plasmids were extracted using the Mini-Plasmid Rapid Isolation Kit (Beijing Bodatech Biotechnology Co., Ltd.). 20 μL of plasmid was taken and sent to Sangon Biotech (Shanghai) Co., Ltd., where DNA sequencing confirmed successful construction.

[0058] Example 3: Induced expression culture of recombinant Escherichia coli

[0059] The recombinant *E. coli* strains constructed in Examples 1 and 2, as well as the recombinant *E. coli* strain from the control group (pET-28a(+) empty vector transformant, used as a negative control), were inoculated into 10 mL of LB liquid medium containing 50 μg / mL kanamycin sulfate and cultured overnight at 37°C with shaking at 200 rpm. 10 mL of the culture was then transferred to 1 L of LB liquid medium containing 50 μg / mL kanamycin sulfate and cultured at 37°C with shaking at 200 rpm until OD (dose retardation). 600The concentration was approximately 0.6-0.8. Isopropyl-β-D-thiogalactoside (IPTG) was added to the culture to a final concentration of 0.5 mM, and the culture was induced at 28℃ and 200 rpm for 12 h. The culture medium was centrifuged at 4℃ and 12000 rpm for 10 min, the supernatant was discarded, and the precipitate (bacterial cells) was collected. The cells were dispersed in 14 mL of 50 mM Tris-HCl buffer (pH 7.5) and sonicated in an ice bath. The sonication parameters were as follows: the ultrasonic power of the ultrasonic cell disruptor (purchased from Ningbo Xinzhi Biotechnology Co., Ltd., model JY92-IIN) was set to 10%, and the sonication time was 30 min (2 s working time, 3 s interval). A portion of the sonicated bacterial cells (i.e., whole cell lysate) was used for SDS-PAGE analysis, and the other portion was centrifuged at 4℃ and 12000 rpm for 10 min. The supernatant and precipitate were then used for SDS-PAGE analysis separately. Figures 1-3 As shown, the SDS-PAGE results indicate that the soluble expression levels of each target protein are high and the molecular weights are correct.

[0060] Example 4 Purification of recombinant protein

[0061] The recombinant *E. coli* strains constructed in Examples 1 and 2 were inoculated into 50 mL of LB liquid medium containing 50 μg / mL kanamycin sulfate and cultured overnight at 37°C with shaking at 200 rpm. 50 mL of the culture was then transferred to 5 L of LB liquid medium containing 50 μg / mL kanamycin sulfate and cultured at 37°C with shaking at 200 rpm until OD (dose eluent) was reached. 600 The concentration is approximately 0.6-0.8. IPTG was added to the culture to a final concentration of 0.5 mM, and the culture was induced at 28°C and 200 rpm for 12 h. The culture solution was centrifuged at 4°C and 12000 rpm for 10 min, the supernatant was discarded, and the precipitate (bacterial cells) was collected. The bacterial cells were washed three times with physiological saline to obtain wet bacterial cells.

[0062] Weigh 20 g of wet bacterial cells and suspend them in 70 mL of 50 mM Tris-HCl buffer (pH 7.5). Sonicate the cells in an ice bath. The sonication parameters were: 10% ultrasonic power and 30 min sonication time (2 s working time, 3 s interval). Centrifuge the sonicated cells at 4°C and 12000 rpm for 10 min, and collect the supernatant as the crude enzyme solution. Purify the crude enzyme solution using a His-Trap HP affinity column. After ultrafiltration and desalting using a 30 KD ultrafiltration tube at 4°C and 6000 rpm for 30 min, obtain a 5 mg / mL pure enzyme solution. Store the obtained maltose phosphorylase and its mutant pure enzyme solutions (5 mg / mL) at 4°C for later use. The pure enzyme solutions required in the following examples are provided in this example; if some pure enzyme solution is insufficient, scale up the process accordingly.

[0063] Example 5: Determination of maltose content by HPLC

[0064] Sample preparation method: Dissolve and dilute the sample with ultrapure water to a maltose content of approximately 1-20 mg / mL, filter it through a 0.22 μm aqueous filter membrane, and then inject the sample for detection.

[0065] HPLC detection method: An Agilent 1260 Infinity HPLC system with a differential refractive index detector was used. The chromatographic column was Sepax Carbomix Ca-NP5:8% (7.8×300 mm, 5 μm). The mobile phase was pure water. The column temperature was 80℃, the flow rate was 0.6 mL / min, the detector temperature was 35℃, and the run time was 16 min.

[0066] Example 6: Enzyme activity assay of maltose phosphorylase and its mutants

[0067] The activity of maltose phosphorylase was determined by detecting the amount of maltose produced. Enzyme activity assay conditions: total reaction volume 10 mL, solvent 50 mM Tris-HCl buffer (pH 7.5), including a final concentration of 150 mg / mL β-D-glucose-1-phosphate (β-G1P), a final concentration of 300 mg / mL D-glucose, and 50 μL of pure enzyme solution (5 mg / mL) of maltose phosphorylase or its mutant prepared in Example 4. The reaction was carried out at 45°C and 200 rpm for 30 min. The reaction was immediately terminated by boiling for 5 min after completion. The maltose content in the reaction solution was detected by HPLC according to the method in Example 5. Enzyme activity was defined as the amount of enzyme required to catalyze the production of 1 μmol of maltose per minute under the above assay conditions.

[0068] The enzyme activity assay results of maltose phosphorylase and its mutants are shown in Table 2.

[0069] Table 2

[0070]

[0071] The results above show that, under the specified conditions, the enzyme activities of all maltose phosphorylase mutants were higher than those of their corresponding wild-type maltose phosphorylases. Specifically, the wild-type maltose phosphorylase TbMP had an activity of 30.2 U / mg, which was superior to both wild-type maltose phosphorylases TsMP and TcMP; its mutant TbMP_V1 exhibited the highest enzyme activity, reaching 48.1 U / mg.

[0072] Example 7: Determination of the thermal stability of maltose phosphorylase and its mutants

[0073] The purified enzyme solutions (5 mg / mL) of maltose phosphorylase and its mutants prepared in Example 4 were taken in mL and incubated in a 60°C water bath for 10, 20, 30, 40, and 50 h. After incubation, the heat-treated samples were immediately transferred to an ice-water bath to terminate the heat treatment, obtaining the heat-treated enzyme solutions. Following the enzyme activity assay method in Example 6, enzyme activity was measured under the same reaction conditions. The highest enzyme activity in the thermostability test was taken as 100%, and the relative enzyme activity at different incubation times was calculated. The results are as follows: Figure 4 As shown in the figure. The results indicate that the thermostability of each maltose phosphorylase mutant at 60℃ is significantly better than that of its corresponding wild-type maltose phosphorylase. Among them, the thermostability of wild-type maltose phosphorylase TbMP is better than that of wild-type maltose phosphorylases TcMP and TsMP; after treatment at 60℃ for 50 h, wild-type maltose phosphorylase TbMP retains 30.5% of its relative enzyme activity, while the maltose phosphorylase mutant TbMP_V1 retains 51.1% of its relative enzyme activity under the same conditions.

[0074] Example 8: Maltose phosphorylase catalyzes the synthesis of maltose from D-glucose and β-D-glucose-1-phosphate.

[0075] The total volume of the reaction system was 100 mL, and the solvent was 50 mM Tris-HCl buffer (pH 7.5), including a final concentration of 150 mg / mL β-D-glucose-1-phosphate (β-G1P), a final concentration of 300 mg / mL D-glucose, and 5 mL of purified enzyme solution (5 mg / mL) of maltose phosphorylase or its mutant prepared in Example 4. The reaction temperature was 50 °C, the stirring speed was 200 rpm, and the reaction time was 5 h. After the reaction was completed, it was immediately boiled for 5 min to terminate the reaction. Following the method in Example 5, the maltose content in the reaction solution was determined by HPLC. The maltose yield was calculated using the formula: Yield (%) = (actual molar concentration of maltose produced / initial molar concentration of β-G1P) × 100%. The results are as follows: Figure 5 As shown, the maltose phosphorylase mutant TbMP_V1 had the highest yield, reaching 92.1%, which is 1.43 times that of the wild-type maltose phosphorylase TbMP (64.5%).

[0076] Example 9 Preparation of maltose phosphorylase and its mutant immobilized enzyme

[0077] The total volume of the immobilization reaction system was 20 mL, and the solvent was 50 mM Tris-HCl buffer (pH 7.5). It included 6 mL of pure enzyme solution (5 mg / mL) of maltose phosphorylase TbMP or its mutant TbMP_V1 obtained in Example 4, 1 g of LX-1000NH amino resin (Xi'an Lanxiao Technology New Material Co., Ltd., the resin is not included in the total volume of the system), 0.5 mL of glutaraldehyde (50% (wt) aqueous solution, MACKLIN, catalog number G810413) and 0.2 mL of polyethyleneimine (purity ≥99% (wt), Aladdin, catalog number E107079). The mixture was stirred at 10 °C and 50 rpm for 6 h, and then filtered to obtain a solid. The solid was washed with 100 mL of deionized water and filtered again to obtain immobilized maltose phosphorylase TbMP or its mutant TbMP_V1.

[0078] Example 10 Maltose phosphorylase and its mutant immobilized enzyme catalyze the synthesis of maltose from D-glucose and β-D-glucose-1-phosphate.

[0079] The total volume of the reaction system was 5 mL, and the solvent was 50 mM Tris-HCl buffer (pH 7.5). It included a final concentration of 150 mg / mL β-D-glucose-1-phosphate (β-G1P), a final concentration of 300 mg / mL D-glucose, and 1 g of maltose phosphorylase TbMP immobilized enzyme or maltose phosphorylase mutant TbMP_V1 immobilized enzyme (prepared in Example 9; the immobilized enzyme was not included in the total volume of the reaction system). The reaction temperature was 50 °C, the stirring speed was 200 rpm, and the reaction time was 5 h. Immobilized enzymes were immediately separated by filtration after the reaction. Following the method in Example 5, the maltose content in the reaction solution was determined by HPLC. The maltose yield was calculated using the formula: Yield (%) = (actual molar concentration of maltose produced / initial molar concentration of β-G1P) × 100%. The results are as follows: Figure 6 As shown, the maltose phosphorylase mutant TbMP_V1 immobilized enzyme catalyzed the synthesis of maltose from D-glucose and β-G1P with a yield of 92.5%, while the maltose phosphorylase TbMP immobilized enzyme catalyzed the synthesis of maltose from D-glucose and β-G1P with a yield of only 66.5%.

[0080] The filtered immobilized enzyme was washed with 10 mL of deionized water and filtered again, then reused in the reaction cycle for a total of 30 cycles. The relative enzyme activity of the immobilized enzyme at different cycles was calculated (with the enzyme activity measured at the 0th cycle of each immobilized enzyme as 100%). The results are as follows: Figure 7 As shown, the maltose phosphorylase mutant TbMP_V1 immobilized enzyme retained 85.8% of its relative enzyme activity after 30 applications, while the maltose phosphorylase TbMP immobilized enzyme retained only 22.3% of its relative enzyme activity under the same conditions.

Claims

1. A maltose phosphorylase mutant, characterized in that, The maltose phosphorylase mutant is the maltose phosphorylase mutant TbMP_V1; The maltose phosphorylase mutant TbMP_V1 is obtained by mutating serine at position 368 to leucine, valine at position 551 to aspartic acid, and asparagine at position 698 to histidine in wild-type maltose phosphorylase TbMP; the amino acid sequence of wild-type maltose phosphorylase TbMP is shown in SEQ ID NO:

5.

2. The gene encoding the maltose phosphorylase mutant of claim 1.

3. A recombinant vector constructed from the encoding gene of the maltose phosphorylase mutant as described in claim 2.

4. The recombinant microorganism obtained by transformation of the recombinant vector according to claim 3.

5. The application of the maltose phosphorylase mutant of claim 1 in the catalytic synthesis of maltose from D-glucose and β-D-glucose-1-phosphate, characterized in that, In application, the maltose phosphorylase mutant is used as a catalyst, and D-glucose and β-D-glucose-1-phosphate are used as substrates. Under controlled temperature and stirring speed conditions, maltose is synthesized by enzyme catalysis in a reaction medium.

6. The application according to claim 5, characterized in that, The reaction medium is a 10-100 mM Tris-HCl buffer solution with a pH of 7.0-8.

0. The final concentration of maltose phosphorylase mutant is 0.025-1.5 mg / mL, the final concentration of D-glucose is 100-400 mg / mL, and the final concentration of β-D-glucose-1-phosphate is 100-300 mg / mL. The temperature is controlled at 40-50°C, the stirring speed is 100-300 rpm, and the reaction time is 1-5 h.

7. The immobilized enzyme prepared from the maltose phosphorylase mutant according to claim 1.

8. The immobilized enzyme according to claim 7, characterized in that, The immobilized enzyme is prepared by the following steps: using 10-100 mM Tris-HCl buffer (pH 7.0-8.0) as solvent, the maltose phosphorylase mutant and amino resin are added, with a mass ratio of 10-100 mg:1 g. The amino resin includes LX-1000NH amino resin. 1% (v / v)-5% (v / v) glutaraldehyde and 1% (v / v)-5% (v / v) polyethyleneimine are added, where the glutaraldehyde is calculated as 50% (wt). The polyethyleneimine is a liquid with a purity ≥99% (wt). The immobilization temperature is 4-10℃, the stirring speed is 20-100 rpm, and the immobilization time is 0.5-6 h. The enzyme is then filtered and washed to obtain the immobilized enzyme.

9. The application of the immobilized enzyme according to claim 7 or 8 in the catalytic synthesis of maltose from D-glucose and β-D-glucose-1-phosphate, characterized in that, In application, the immobilized enzyme is used as a catalyst, and D-glucose and β-D-glucose-1-phosphate are used as substrates. Under controlled temperature and stirring speed conditions, maltose is synthesized by enzyme catalysis in a reaction medium.

10. The application according to claim 9, characterized in that, The reaction medium is a 10-100 mM Tris-HCl buffer solution with a pH of 7.0-8.

0. The final concentration of the immobilized enzyme is 50-200 mg / mL, the final concentration of D-glucose is 100-400 mg / mL, and the final concentration of β-D-glucose-1-phosphate is 100-300 mg / mL. The temperature is controlled at 40-50°C, the stirring speed is 100-300 rpm, and the reaction time is 1-5 h.